Mar 15 2010
FGX International Holdings Limited (Nasdaq: FGXI) (“FGX International”)
announced that it has completed its merger with a subsidiary of Essilor
International (“Essilor”) of Charenton-le-Pont, France.
“We are excited to be a part of Essilor and look forward to doing great
things together”
FGX International shareholders received $19.75 per share in cash, for an
aggregate value of approximately $575 million, including the repayment
of FGX International debt of approximately $115 million. Upon completion
of the merger, FGX International became a wholly-owned subsidiary of
Essilor and its shares ceased to be publicly traded on the NASDAQ Global
Select Market. Following the merger, FGX International will change its
place of incorporation from the British Virgin Islands to the State of
Delaware.
“We are excited to be a part of Essilor and look forward to doing great
things together,” said Alec Taylor, FGX International’s Chief Executive
Officer.
The world leader in ophthalmic optical products, Essilor International
researches, develops, manufactures and markets around the world a wide
range of lenses to correct myopia, hyperopia, presbyopia and
astigmatism. Its flagship brands are Varilux®, Crizal®, Essilor®,
Definity® and Xperio™. Based in France, the company reported
consolidated revenue of €3.2 billion in 2009, with 34,700 employees and
operations in 100 countries. For more information, please visit www.essilor.com.The
Essilor share trades on the NYSE Euronext Paris market and is included
in the CAC 40 index. Codes and symbols: ISIN: FR FR0000121667; Reuters:
ESSI.PA; Bloomberg: EI:FP.
Source FGX International Holdings Limited